Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 22

The future of neurotechnology | Sri Sarma | TEDxBoston

NOTE FROM TED: This talk only represents the speaker’s personal approach to and understanding of neural systems, technology, and defense. TEDx events are independently organized by volunteers. The guidelines we give TEDx organizers are described in more detail here: http://storage.ted.com/tedx/manuals/t…

Autonomous systems can process vast amounts of information—but they struggle when the unexpected happens. The human brain, by contrast, thrives in uncertainty. In this provocative talk, Sri Sarma reveals how merging machine intelligence with living neural systems could create a new class of adaptive technologies, from resilient autonomous vehicles to precision therapies that operate inside the human body. The nations that lead this future in \.

Oxalate buildup triggers systemic inflammation and cardiac damage, study shows

People with chronic kidney disease (CKD) have a significantly increased risk of death from cardiovascular disease. They also suffer from chronic inflammation, the causes of which are still only partly understood. Oxalic acid (oxalate) has so far been known primarily for its role in the formation of kidney stones. The molecule is a natural metabolic byproduct, is found in certain foods and is normally excreted by the kidneys in urine. However, when kidney function is impaired, oxalate accumulates in the body and can promote inflammatory processes.

The Experimental Biomedicine II department at Würzburg University Hospital (UKW), together with the Experimental and Clinical Research Center (ECRC), a joint institution of Charité—Universitätsmedizin Berlin and the Max Delbrück Center, investigated the immunological mechanisms linking oxalate-induced kidney damage with systemic inflammation and cardiovascular injury.

“In our research project, an oxalate-enriched diet activated the immune system systemically in mice. In other words, inflammatory processes spread throughout the body. This led not only to kidney damage, but also to pathological changes in the heart that reduced cardiac function,” says Dr. Hendrik Bartolomaeus. The scientist, who is part of Professor Alma Zernecke-Madsen’s team at UKW, shares senior authorship of the study with Dr. Nicola Wilck of ECRC. The study was published in Cardiovascular Research. Bartolomaeus previously worked in Wilck’s laboratory.

Nanoparticles could remove harmful immune molecules from blood

The immune system, the body’s defense network against infections and injuries, can sometimes become too active. In these cases, it can produce too many immune mediators, fragments of genetic material or proteins that regulate immune responses.

An excess of these molecules in the bloodstream can cause severe inflammation, sometimes leading to life-threatening medical conditions such as sepsis and acute lung injury. Sepsis is an extreme and life-threatening response to a bacterial, viral or fungal infection. Acute lung injury, on the other hand, occurs when inflammation causes fluid to leak into the lungs, impairing breathing and potentially leading to respiratory failure.

Some biomedical scientists and engineers have been trying to identify promising solutions to remove these excess immune mediators from the bloodstream. Some proposed approaches rely on lysosome-targeting chimeras (LYTACs), molecules that could remove proteins outside or on the surface of cells, directing them to lysosomes (i.e., organelles that dispose of or recycle food particles and other cell waste).

Machine learning improves identification of asthma risk in children

A machine learning tool that analyzes information already captured in a child’s electronic health record helped pediatricians more accurately assess asthma risk in standardized clinical case scenarios, according to a pilot randomized clinical trial led by a Regenstrief Institute researcher. The study was published in Scientific Reports.

The study evaluated a machine learning-enabled clinical decision support tool called the Passive Digital Marker, which uses routinely collected EHR data to classify young children as having a high or low risk of developing persistent asthma.

Asthma is one of the most common chronic childhood diseases, but predicting which young children with wheezing or other respiratory symptoms will go on to develop persistent asthma remains difficult. While some children outgrow these symptoms, others require ongoing treatment, making early risk assessment an important but challenging part of pediatric care.

CD8+ T cells in atherosclerosis and coronary artery disease

In this Review, Hossam Abdelsamed and colleagues discuss the different phenotypes and functions of CD8+ T cell subsets at different stages of atherosclerosis, as well as their roles in common comorbidities of atherosclerotic cardiovascular disease. The authors also highlight potential therapeutic strategies targeting CD8+ T cells and key knowledge gaps in our understanding of the role of these cells in atherosclerosis.

Scientists use relay synthesis to create key building blocks of reserve antibiotic to combat resistance

Chemists from Otto von Guericke University Magdeburg have achieved an important research success in the fight against resistant bacteria. The team led by scientist Professor Dr. Dieter Schinzer from the Institute of Chemistry has succeeded in producing key building blocks of the naturally occurring substance Neosorangicin A in the laboratory for the first time. This means it is now possible to develop Neosorangicin A in a targeted manner as a promising reserve antibiotic candidate to combat antibiotic resistance in the future.

To artificially produce the naturally occurring substance, the scientists used what is known as relay synthesis—instead of immediately creating the entire complex molecule, they first synthesized the critical sections, which served as staging points en route to the complete substance. The research success lies not only in the components produced but also in proof of the development process. The results have just been published in the journal Chemistry—A European Journal.

4D force patterning enables spatial control of angiogenesis

When the engineers used gene editing to suppress the PIEZO1 gene, the cells became “deaf” to the physical tugging. Even when the magnets vigorously exercised the gel, the blood vessels barely sprouted at all. This proved that physical force directly activates this cellular gatekeeper, signaling the vessel that it’s time to grow and branch out.

Engineering organized microvascular networks remains a critical challenge in tissue engineering and regenerative medicine. While biochemical approaches for patterning angiogenesis via growth factor delivery have shown promise, their inability to pattern sustained growth factors with spatiotemporal control limits effectiveness. Here, we demonstrate that dynamically patterned mechanical forces enable precise spatiotemporal control over angiogenic sprouting. We developed a magnetically actuated human vessel-on-a-chip platform that integrates a perfusable endothelialized microchannel within a collagen matrix and allows noninvasive and tunable mechanical stimulation across three spatial dimensions and time (4D). Using an automated 3-axis actuator, we systematically investigated how strain magnitude, frequency, and direction modulate endothelial cell behavior and vessel morphogenesis.

Aged Cells Can Revert Into Stem Cells To Regenerate Damaged Tissue

Welcome to functional immortality, folks.

I say functional rather than absolute because no one will ever REALLY live FOREVER. Even if we can reverse aging and become immune to all diseases (which is exactly what is happening right now even as I write this) there will still be accidents, suicides, wars, and murders. — Still…a BILLION years would be enough for me.

What about you?

A new study reveals that mature cells retain the ability to transform into stem cells after injury. The regenerative process, driven by macrophages, may offer new strategies for repairing damaged tissues.

China Built An AI Doctor — And It’s Already In 300 Hospitals

This video breaks down exactly how China went from launching a national smart hospital initiative back in 2014 to deploying AI inside over three hundred hospitals by 2025, and eventually opening the world’s first fully integrated AI hospital in March 2026. You’ll see how AI triage systems, robotic pharmacies, and real-time diagnostic assistants are changing what a hospital visit actually looks like, and how this compares to healthcare systems elsewhere that are still struggling with weeks-long appointment waits and fax machines. Whether you find this exciting or concerning, this is a story about where healthcare technology is headed next, and it’s already happening.

/* */